2010 Cannabis Clinical Trials Data 
Project CBD
MARCH 21, 2023
The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. Among the 45 respondents, median age 55, only 10 said they were current cannabis users (19 had never used, and 16 had used in the past).
Healer
MARCH 26, 2021
Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. March 19, 2021.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Greencamp
AUGUST 16, 2018
In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Let’s explore this in more detail. What exactly is ALS?
Cannabis Law Report
JULY 6, 2021
He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” Johnson received the R. Brinkley Smithers award from the American Association of Addiction Medicine.
Cannabis Law Report
JUNE 10, 2021
In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. However, relatively few studies have used self-reported data for this purpose [ 11 , 12 , 13 ]. Under this restriction, we analyzed data from 11,816 respondents.
Project CBD
FEBRUARY 27, 2023
But there’s another option that can address mood, pain, and more at once, all with fewer side effects: cannabis. Nor is it necessarily surprising, given the ability of cannabis to target the ubiquitous, homeostasis-seeking endocannabinoid system. It’s not a new idea.
Cannabis Law Report
JULY 28, 2021
The results also provide confidence in the Company’s plan to dedicate resources to advance PD-001 through FDA IND-enabling studies to support Phase 1 and 2 clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer. ” Next Steps.
Expert insights. Personalized for you.
144 
Let's personalize your content